MATRIX PHARMACEUTICALS ApS: Financial statements 2013
CVR: 29625867
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MATRIX PHARMACEUTICALS ApS (CVR 29625867) has filed annual accounts for 2013. In 2013, the company reported revenue of DKK 8,648,304 and a net result of DKK 961,193 compared with DKK 78,904 the year before. That is an increase of 93.9% compared with the year before. The profit margin was 11.1%. Equity in the 2013 report amounted to DKK -167,143.
- Revenue
- DKK 8,648,304
- Gross Profit
- DKK 1,151,640
- Profit/Loss
- DKK 961,193
- Equity
- DKK -167,143
- Total Assets
- DKK 3,147,882
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | 8.6 mio. | 1.2 mio. | 961 t. | -167 t. | - |
| 2012 | 4.5 mio. | 264 t. | 79 t. | -1.1 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MATRIX PHARMACEUTICALS ApS has published its annual report for 2012. Revenue came to DKK 4,460,599, and the net result was DKK 78,904.
As of May 15, 2013, Anders Leif Håkansson has joined the board of directors of MATRIX PHARMACEUTICALS ApS.
As of May 15, 2013, Peter Lassen has left the board of directors of MATRIX PHARMACEUTICALS ApS.
About MATRIX PHARMACEUTICALS ApS
MATRIX PHARMACEUTICALS ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2006. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Karsten Høilund Skafte. The board consists of Karsten Høilund Skafte. The company is owned by Karsten Høilund Skafte and KHS HOLDING ApS. The company has 1 employee (2018). In 2025, the company reported revenue of DKK 1,090,380 and a net result of DKK 589,123 compared with DKK 440,028 the year before. Equity in the 2025 report amounted to DKK 589,123.